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The molecular mechanisms that define asymptomatic bacteriuria (ABU) Escherichia coli colonization of the human urinary tract
remain to be properly elucidated. Here, we utilize ABU E. coli strain 83972 as a model to dissect the contribution of siderophores
to iron acquisition, growth, fitness, and colonization of the urinary tract. We show that E. coli 83972 produces enterobactin, sal-
mochelin, aerobactin, and yersiniabactin and examine the role of these systems using mutants defective in siderophore biosyn-
thesis and uptake. Enterobactin and aerobactin contributed most to total siderophore activity and growth in defined iron-
deficient medium. No siderophores were detected in an 83972 quadruple mutant deficient in all four siderophore biosynthesis
pathways; this mutant did not grow in defined iron-deficient medium but grew in iron-limited pooled human urine due to iron
uptake via the FecA ferric citrate receptor. In a mixed 1:1 growth assay with strain 83972, there was no fitness disadvantage of the
83972 quadruple biosynthetic mutant, demonstrating its capacity to act as a “cheater” and utilize siderophores produced by the
wild-type strain for iron uptake. An 83972 enterobactin/salmochelin double receptor mutant was outcompeted by 83972 in hu-
man urine and the mouse urinary tract, indicating a role for catecholate receptors in urinary tract colonization.
Urinary tract infections (UTIs) are among the most commoninfectious diseases of humans, with Escherichia coli responsi-
ble for 80% of cases (51). Approximately 50% of women will
experience cystitis in their lifetime and asymptomatic bacteriuria
(ABU) occurs in 6 to 20%of the population depending on age and
gender (21). ABU is an asymptomatic carrier state that resembles
commensalism with patients often carrying 105 CFU/ml of
urine of a single organism. Many ABU E. coli isolates are phyloge-
netically related to virulent uropathogenic E. coli (UPEC) strains
and some may have evolved from pathogenic strains by virulence
attenuation (43, 68).
Iron is essential for bacterial growth and is limited in the uri-
nary tract. Therefore, iron acquisition systems are important col-
onization factors for ABU E. coli and UPEC. An efficient method
for the sequestration of iron is through the production of sidero-
phores, low-molecular-weight Fe3-chelating compounds, and
subsequent uptake via their associated membrane receptors (11,
44). At present four different siderophore systems have been iden-
tified in E. coli. Enterobactin is a highly prevalent catecholate sid-
erophore produced by both E. coli K-12 strains and pathogenic
strains (12, 32). While enterobactin has a very high stability con-
stant for Fe3 binding, it is inactivated by host proteins such as
serum albumin and siderocalin (neutrophil gelatinase-associated
lipocalin) (24, 38). Salmochelin, a glucosylated derivative of en-
terobactin, is not recognized by siderocalin and thus evades the
host immune response (19). Salmochelin biosynthesis and utili-
zation require the iroBCDEN gene cluster as well as the enterobac-
tin biosynthesis and utilization genes. Yersiniabactin is a mixed-
type siderophore encoded on the high-pathogenicity island that is
widespread in Enterobacteriaceae. The yersiniabactin biosynthesis
and uptake system is a virulence determinant in Yersinia species,
Klebsiella pneumoniae and several E. coli pathotypes (6, 40, 56).
Aerobactin, a hydroxamate siderophore, has a higher Fe3 bind-
ing stability in acidic environments and is maximally produced at
low pHs (62).
All four siderophore systems are negatively regulated by fer-
rous iron and the ferric uptake regulator Fur and are expressed
under low-iron conditions (5, 8). E. coli clinical isolates encode
and express different combinations of the four siderophores (32,
43). Indeed, studies have shown that the siderophore systems are
highly expressed by ABU E. coli andUPEC isolates in vitro in urine
and in patients during UTI (3, 27, 52, 54, 58). Transcriptome
analysis of E. coli in urine from women with UTIs revealed that
iron acquisition systems were the most highly expressed fitness
factors common to all patients (27). Siderophore systems are also
required for UPEC virulence in the mouse urinary tract (23, 60).
Additionally, several iron receptors, including the aerobactin re-
ceptor protein IutA, are potential vaccine candidates since they
protect mice from infection with UPEC (2). However, the relative
contribution of each siderophore system to the growth and sur-
vival of E. coli isolates encoding all four systems is not well under-
stood. Furthermore, although some UPEC strains contain the
genes encoding siderophore receptors, they fail to express the as-
sociated functional siderophore molecule (32).
One of the best-characterized ABU strains is E. coli 83972, a B2
clinical isolate capable of long-term bladder colonization that has
been effectively employed as a prophylactic agent for the preven-
tion of UTI in human inoculation studies (4, 33, 42, 59, 65). Blad-
der infectionwith E. coli 83972 fails to induce a host inflammatory
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response and this is associated with the attenuation of virulence
determinants including type 1, P and F1C fimbriae (37, 53, 64).
With a limited adhesin repertoire, a significant contributing factor
to the maintenance of E. coli 83972 in the bladder is its rapid
growth rate in urine (54). E. coli 83972 contains genes encoding
the enterobactin, salmochelin, aerobactin and yersiniabactin sid-
erophore systems. Transcription of these siderophore genes is
highly upregulated during growth of E. coli 83972 in the bladder of
deliberately colonized patients, suggesting that siderophores may
contribute to urinary tract colonization (29, 52). Differences in
iron acquisition have also been proposed as a mechanism by
which ABU E. coli outcompetes UPEC in human urine (54). In
this study we have defined the specific complement of sidero-
phores produced by E. coli 83972. In addition, we have used E. coli
83972 to extensively study the contribution of enterobactin, sal-
mochelin, aerobactin and yersiniabactin to total siderophore ac-
tivity and growth in iron-limited environments as well as in vitro
and in vivo fitness.
MATERIALS AND METHODS
Bacterial strains and growth conditions.The clinical ABU E. coli isolates
were obtained from urine samples of patients at the Princess Alexandra
Hospital (Brisbane, Australia) and have been described previously (43).
Additional bacterial strains utilized in this study are described in Table 1.
E. coli 83972 (OR:K5:H) is a prototype ABU clinical strain originally
isolated from a young Swedish girl who carried it for 3 years without
adverse effects (4, 42). E. coli 83972AMP contains the ampicillin resistance
gene inserted at the -attachment site and was used in competition exper-
iments (17). Strains were routinely grown at 37°C in MM9-glycerol min-
imalmediumas previously described (63)with the addition of 0.3%Casa-
mino Acids, 0.02% thiamine-HCl and 0.2% sodium succinate. Where
indicated, 0.2% glucose was used as the carbon source instead of 0.2%
glycerol and the pH was adjusted to pH 5.5 or pH 7.0. Human urine was
collected from at least three healthy female volunteers with no history of
UTI or antibiotic use in the previous 2 months. Pooled urine was filter
sterilized and used within 3 days. To ensure iron limitation plasticware
was used and 50M2,2=-dipyridyl (DIP)was added to themediumwhere
indicated. Luria-Bertani (LB) agar plates were supplemented with appro-
priate antibiotics as indicated in the following final concentrations: 50g
ml1 kanamycin (Kan), 50 g ml1 ampicillin (Amp), and 15 g ml1
chloramphenicol (Cam).
Construction of E. coli 83972 iron acquisition deletion mutants. E.
coli 83972 iron acquisition genes were deleted using the  Red recombi-
nase gene inactivation method as previously described (14). Plasmids
pKD4 and pKD3 were used as the templates for siderophore biosynthetic
gene and siderophore receptor gene deletion mutants, respectively, using
the primers listed in Table S1 in the supplemental material. Ferric citrate
TABLE 1 Bacterial strains used in this study
E. coli strain or deletion mutant Description Reference or source
83972 wild-type ABU strain 42
83972AMP 83972 attB::bla-rrnBP1-cfp-T0; Ampr 17
Siderophore biosynthetic gene deletion mutants
83972 A 83972 iucABCD (aerobactin); Kanr This study
83972 Y 83972 ybtS (yersiniabactin); Kanr This study
83972 S 83972 iroB (salmochelin); Kanr This study
83972 ES 83972 entB (enterobactin/salmochelin); Kanr This study
83972 AS 83972 iucABCD iroB; Kanr This study
83972 SY 83972 iroB ybtS; Kanr This study
83972 AY 83972 iucABCD ybtS; Kanr This study
83972 ASY 83972 iucABCD iroB ybtS; Kanr This study
83972 EAS 83972 entB iucABCD; Kanr This study
83972 ESY 83972 entB ybtS; Kanr This study
83972 EASY 83972 entB iucABCD ybtS; Kanr This study
Siderophore receptor gene deletion mutants
83972 AR 83972 iutA (aerobactin); Camr This study
83972 YR 83972 fyuA (yersiniabactin); Camr This study
83972 ER 83972 fepA (enterobactin); Camr This study
83972 SR 83972 iroN (salmochelin); Camr This study
83972 ASR 83972 iutA iroN; Camr This study
83972 SYR 83972 iroN fyuA; Camr This study
83972 AYR 83972 iutA fyuA; Camr This study
83972 EYR 83972 fepA fyuA; Camr This study
83972 ESR 83972 fepA iroN; Camr This study
83972 EAR 83972 fepA iutA; Camr This study
83972 ASYR 83972 iutA iroN fyuA; Camr This study
83972 EASR 83972 fepA iutA iroN; Camr This study
83972 EAYR 83972 fepA iutA fyuA; Camr This study
83972 ESYR 83972 fepA iroN fyuA; Camr This study
83972 EASYR 83972 fepA iutA iroN fyuA; Camr This study
Ferric citrate receptor gene deletion mutants
83972 F 83972 fecA (ferric citrate receptor); Kanr This study
83972 EASYF 83972 entB iucABCD ybtS fecA; Kanr This study
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receptormutants were constructed using pKD4. Plasmid pCP20, express-
ing the FLP recombinase, was transformed into each deletion mutant to
remove the antibiotic resistance cassette prior to subsequent gene dele-
tions. Single, double, triple and quadruple siderophoremutantswere con-
structed.Deletion of the enterobactin biosynthetic gene entB abolishes the
synthesis of both enterobactin and salmochelin (ES). All deletionmutants
were verified by PCR and DNA sequencing. Mutants with multiple dele-
tions were reconfirmed by PCR once the final deletion had beenmade; all
mutationswere correct with no evidence of recombination betweenRed
recombinase deletion sites. Mutants utilized in the assays contained the
antibiotic resistance cassette used to construct the last mutation; this al-
lowed for selective plating on LB agar plates with antibiotics for the com-
petition assays. Antibiotics were not added to growth medium for any of
the assays and therefore did not interfere with growth of the mutants.
Growth and competition assays. For growth assays, strains grown for
16 h in MM9-glycerol medium were used to inoculate 25 ml of MM9-
glycerolmediumwith 50MDIP to an optical density at 600 nm (OD600)
of 0.05. Cultures were grown with shaking at 37°C, with OD600 measure-
ments taken every hour. For competition assays, strains grown for 16 h in
MM9-glycerol medium were mixed 1:1 to a final OD600 of 0.05 in MM9-
glycerol medium with 50 M DIP. Cultures were grown with shaking at
37°C,with samples plated onLB agarwith appropriate antibiotics at 0-, 7-,
and 24-h time points. Growth and competition assays in pooled human
urine were performed as described above, with and without 50 M DIP.
For competition experiments E. coli 83972AMP was used as the wild-type
83972 strain. E. coli 83972AMP possessed a growth rate identical to that of
E. coli 83972 in MM9 medium and pooled human urine and showed no
significant difference in fitness when competed against E. coli 83972 in
mixed growth assays.
CAS assays. For liquid chrome azurol S (CAS) assays, strains were
grown inMM9-glycerolmediumat pH5.5 or pH7.0,with shaking at 37°C
for 16 h. OD600 measurements of the cultures were taken before the cells
were pelleted and the supernatants were collected. Liquid CAS assays were
performed using the culture supernatants as previously described (57).
Siderophore levels were standardized by the OD600 measurements to ac-
count for slight variations in growth with percent siderophore units cal-
culated as previously described (46). For solid CAS assays agar plates
based on MM9 medium with 0.2% glycerol or 0.2% glucose at pH 5.5 or
pH 7.0 were made as previously described (57). Strains were grown in
MM9 medium with 0.2% glycerol or 0.2% glucose at pH 5.5 or pH 7.0
with shaking at 37°C for 17 h. The cultures were standardized to anOD600
of 0.5 before 2l of each strain was spotted onto the CAS agar plates. The
plates were incubated at 37°C for 17 h. The radius of the halo formed
around each colony wasmeasured from the colony edge to the edge of the
color change and corresponds with the amount of siderophore activity.
The term “siderophore activity” refers to the level of siderophore as mea-
sured using either liquid or solid CAS assays.
Extraction and high-performance liquid chromatography (HPLC)/
LC-mass spectrometry (MS) analysis of siderophores. E. coli 83972
strains were grown for 3 h in LB medium, diluted 1:100 into 25 ml of
MM9-glycerol medium pH 7.0 and incubated for 17 h with shaking at
37°C. Ferric chloride was added to culture supernatants to a final concen-
tration of 3.75mMand supernatants were left at room temperature for 15
min before the precipitate was removed. Supernatants were added to a
columnfilledwith 1ml ofDEAE-Sepharose (Sigma), and then the column
was washed with 3 ml of water. Siderophores were eluted from the DEAE
with 3 ml of 7.5 M ammonium formate pH 3.6, desalted using Chrom P
solid-phase extraction tubes (250 mg; Supelco), and concentrated to 200
l as previously described (32).
AnalyticalHPLCwas performed on a Shimadzu LC-20AT liquid chro-
matograph (flow rate of 1 ml/min) equipped with a Shimadzu SPD-20A
UV-visible light (Vis) detector (220 nm), column oven (30°C), and Phe-
nomenex HPLC column (Luna C18; 5-mparticle size; 250 by 4.60 mm).
Analytical HPLC analyses were performed with a 60-l injection volume
of the above-prepared siderophore solution, using the following method:
gradient of 6 to 40% aqueous CH3CN containing 0.1% formic acid over
20 min, followed by a hold at 40% for the next 10 min. LC-MS analyses
were performed on aWaters 2690 liquid chromatograph (flow rate of 0.5
ml/min) equipped with a Waters 2487 dual-wavelength absorbance de-
tector (220 nm), column oven (30°C), and Phenomenex HPLC column
(Luna C18; 5-m particle size; 250 by 4.60 mm) that was coupled to a
Waters Quattro Micro API (atmospheric pressure ionization) mass spec-
trometer. MassLynx software (Waters) was used for data acquisition and
processing. LC-MS analyses were performed with a 60-l injection vol-
ume, using the following method: 6 to 40% aqueous CH3CN containing
0.1% formic acid over 40min, with a hold at 40% for the next 20min. The
cone voltage and desolvation temperature were 50 V and 150°C, respec-
tively.
Mousemodel of UTI. Female C3H/HeJMice (8 to 10 weeks old) were
purchased from the Animal Resources Centre, Western Australia and
housed in sterile cages with ad libitum access to sterile water. The mouse
model of UTI with competitive mixed infection was performed as previ-
ously described (1). Mice were inoculated with a mixture of 2.5  108
CFU of E. coli 83972AMP and 2.5  108 CFU of an E. coli 83972 sidero-
phore receptor mutant, both grown for 20 h in LB medium. Urine was
collected from each mouse 42 h after inoculation for quantitative colony
counts. Mice were euthanized 42 h after inoculation; the bladders and
kidneys were excised and processed for quantitative colony counts. The
mixed strains were differentiated by their antibiotic resistance with ampi-
cillin resistant E. coli 83972AMP and the 83972 siderophore mutants resis-
tant to chloramphenicol. Data are expressed as the number of CFUper 0.1
g of bladder or kidney tissue or as the number of CFU per ml of urine.
Fitness indexes were calculated by dividing the CFU count per ml or per
0.1 g of tissue for each 83972 siderophoremutant by that of 83972AMP. All
experiments were carried out in strict accordance with the recommenda-
tions in the Animal Care and Protection Act (Queensland, Australia,
2002) and the AustralianCode of Practice for the Care andUse of Animals
for Scientific Purposes (7th ed., 2004). Approval formouse infection stud-
ies was obtained from the University of Queensland Animal Ethics Com-
mittee (SCMB/471/09/NHMRC [NF]).
Statistical analysis. Variation in siderophore activity of ABU E. coli
isolates grown under different conditions was tested using a Kruskal-
Wallis test with Minitab (version 14) statistical software. Differences in
siderophore activity of E. coli 83972 strains were tested using unpaired
two-sample t tests. The 630-nm absorbance data, standardized by the
OD600 measurements to account for variations in growth, were utilized.
Differences in growth rates and cell densities at the 10-h time point be-
tween E. coli 83972 strains were tested using unpaired two-sample t tests.
For the in vitro competition assays, differences in bacterial CFU/ml of the
E. coli 83972 siderophoremutants compared to E. coli 83972AMPwere also
tested using paired two-sample t tests. For themouseUTImodel, bacterial
CFU counts were compared using a nonparametric Wilcoxon matched-
pairs signed rank test with GraphPad Prism (version 5) statistical soft-
ware. For all tests, the level of statistical significance was set at a P value of
0.05.
RESULTS
Siderophore activity ofABUE. coli clinical isolates under differ-
ent environmental conditions does not correspond with geno-
type. In order to gain an overview of siderophore biosynthesis by
ABUE. coli, we investigated the siderophore activity of a collection
of clinical ABU E. coli isolates, as well as of the prototype ABU E.
coli strain 83972, grown under different conditions. Chrome
azurol S (CAS) agar assays were performed with glucose or glyc-
erol as the carbon source and at pH 5.5 or pH 7.0. Siderophore
activity was significantly lower in cultures grown with glucose at
pH 5.5 than under the three other conditions (P 0.001) (Fig. 1).
We then investigated whether high siderophore activity (defined
as3mm radius) correlated with the presence of the siderophore
ABU E. coli Siderophore Production
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receptor gene iutA (aerobactin), iroN (salmochelin), or fyuA (ye-
rsiniabactin) as previously determined by PCR screening (43). No
correlation between the presence of a specific gene (or any com-
bination of genes) and the level of siderophore activity was appar-
ent for the ABU isolates under any of the four growth conditions.
We then focused our attention on ABU strain E. coli 83972 to
determine its siderophore content and to evaluate how each sid-
erophore system contributes to total siderophore activity, growth,
fitness, and colonization of the urinary tract.
ABU E. coli strain 83972 produces the full repertoire of sid-
erophores encoded by its genome.Todetermine ifE. coli 83972 is
capable of producing enterobactin, aerobactin, salmochelin, and
yersiniabactin, siderophore extraction and LC and LC-MS analy-
ses were performed following growth of E. coli 83972 in MM9
medium. In addition, a series of mutants containing deletions in
the siderophore biosynthetic genes of E. coli 83972 were made to
give single, double, triple, and quadruple siderophore biosyn-
thetic mutants. Throughout the manuscript, these mutants are
labeled according to the iron acquisition gene that was deleted:
enterobactin (E), aerobactin (A), salmochelin (S), yersiniabactin
(Y), and ferric citrate receptor (F). For example, the quadruple
enterobactin, aerobactin, salmochelin, and yersiniabactin mutant
is referred to as 83972 EASY. In LC and LC-MS analyses, wild-type
E. coli 83972 gave peaks that were consistent with the presence of
all four siderophores, while siderophore biosynthetic mutants
83972 AY, ASY, ESY, EAS, and EASY produced the expected sid-
erophore profiles (Fig. 2). Strain 83972 ASY, a triple mutant with
deletions in all siderophore gene clusters except enterobactin, gave
peaks corresponding to enterobactin, linearized enterobactin, and
the 2,3-dihydroxybenzoylserine dimer (DHBS)2. Strain 83972AY,
with intact gene clusters for both enterobactin and salmochelin,
showed additional peaks for salmochelin S1, S2, and S4 as well as
monoglucosyl-enterobactin. As expected, single peaks were seen
for the biosynthetic mutants 83972 ESY and 83972 EAS corre-
sponding to Fe3-aerobactin and Fe3-yersiniabactin, respec-
tively. Therefore, E. coli 83972 can produce all four siderophores
encoded in its genome. The lack of peaks for the quadruple bio-
synthetic mutant 83972 EASY strongly suggests that this strain
does not produce any additional, uncharacterized siderophores.
E. coli 83972 relies primarily on aerobactin and enterobactin
for iron acquisition in iron-limiting medium. In order to assess
the relative importance of each siderophore to iron acquisition by
E. coli 83972 in vitro, total siderophore activity of wild-type 83972
and siderophore biosynthetic mutants was examined via liquid
CAS assays.MM9medium at pH 5.5 and pH 7.0 was utilized since
the pH of human urine varies from pH 4.6 to 8, and the optimal
pH for iron chelation varies for each siderophore (62). E. coli
83972 displayed high siderophore activity in MM9 medium at
both pH5.5 andpH7.0 (Fig. 3). In contrast, the quadruplemutant
83972 EASY had negligible siderophore activity, corresponding to
abolishment of the four siderophore systems. E. coli 83972 single
siderophore mutants showed variation in siderophore levels.
Strain 83972 A, which cannot produce aerobactin, showed 53%
and 25% decreases in siderophore activity compared to the wild-
type strain at pH 5.5 and pH 7.0, respectively (P  0.05). Strain
83972 ES, deleted for enterobactin (and therefore also salmoche-
lin), showed a 53% decrease in siderophore activity at pH 7.0
compared to the wild-type (P 0.001). In contrast, strains 83972
Y and 83972 S, with deletions in yersiniabactin and salmochelin
synthesis genes, respectively, showed no difference in siderophore
activity compared to the wild-type at either pH. Biosynthetic mu-
tants with only one siderophore system left intact—83972 EAS
(yersiniabactin only), 83972 ESY (aerobactin only), and 83972
ASY (enterobactin only)—all demonstrated significant sidero-
phore activity compared to the quadruple mutant 83972 EASY at
pH 5.5 (P 0.05). Taken together, this demonstrates that yersini-
abactin, aerobactin, and enterobactin are all functional sidero-
phores in E. coli 83972. Since deletion of an enterobactin synthesis
gene also abolishes salmochelin synthesis, it was not possible to
analyze a strain which produces only salmochelin.
Theability ofE. coli83972 to growefficiently in iron-limiting
medium requires synthesis of enterobactin and aerobactin.The
E. coli 83972 siderophore biosynthetic mutants were utilized to
examine how each siderophore system contributes to the ability to
grow in iron-limiting medium. Growth curves were established
for E. coli 83972 and each siderophore biosynthetic mutant in
MM9mediumat pH7.0, supplementedwith 50MDIP to ensure
iron limitation. Strains 83972 A, 83972 S, 83972 AY, 83972 AS,
and 83972ASYhad no change in growth compared towild-type E.
coli 83972 (data not shown). However, all mutants with entero-
bactin gene deletions (ES) had significantly lower growth rates
and cell densities after 10 h of growth than wild-type E. coli 83972
(Fig. 4A). For these ES mutants, two growth patterns were appar-
ent. Strains 83972 ES and 83972 ESY showed moderate decreases
in growth rates (35% and 23%, respectively) and cell densities
after 10 h of growth (27% and 21%, respectively) compared to
wild-type E. coli 83972 (P 0.05). In contrast, strains 83972 EAS
and 83972 EASY were severely compromised compared to wild-
type E. coli 83972 for growth rates (88% and 89%, respectively)
and cell densities after 10 h of growth (69% and 79%, respec-
tively); these levels were also significantly lower than those of the
ES and ESY mutants (P  0.05). Strains 83972 Y and 83972 SY
displayed higher growth rates (63% and 71%, respectively) and
higher cell densities after 10 h of growth (31% and 34%, respec-
tively) than wild-type E. coli 83972 (P  0.05) (Fig. 4A). This
increase in growthwas not seenwith 83972 yersiniabactin deletion
FIG 1 Total siderophore activity of ABU E. coli isolates (n  47). Solid CAS
assays were performed with glucose or glycerol as the carbon source and at pH
5.5 or pH 7.0. The radius of the halo formed around each colony corresponds
with the amount of siderophore activity. The data are presented as box plots
with crosses representing the medians. ABU E. coli siderophore activity was
significantly lower when cultures were grown with glucose at pH 5.5 than
under the other growth conditions (P  0.001). The siderophore activity of
ABU E. coli 83972 is indicated.
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strains that were also deleted for enterobactin or aerobactin syn-
thesis genes.
To determine if the siderophores had different contributions
to growth in a more acidic environment, growth assays were also
performed inMM9medium containing 50MDIP at pH 5.5. All
but one 83972 siderophore biosyntheticmutant followed the same
trend as for pH 7.0 (Fig. 4B). The exception was strain 83972 ESY,
which showed no significant decrease in growth rate compared to
wild-type E. coli 83972 at pH 5.5. E. coli 83972 siderophore bio-
synthetic mutants had no change in growth compared to wild-
type E. coli 83972 when grown in MM9 medium without DIP,
suggesting that growth defects were iron dependent (data not
shown).
E. coli 83972 siderophore biosyntheticmutants act as “cheat-
ers.” To determine if the growth deficiencies of the E. coli 83972
siderophore biosynthetic mutants could be rescued by mixed
FIG 2 Siderophores synthesized by ABU E. coli strain 83972. (A) HPLC analysis showing siderophores synthesized by ABU E. coli strain 83972 wild-type (WT)
and 83972 siderophore biosynthetic deletion mutants in MM9medium at pH 7.0. The identity of each peak was confirmed by LC-MS. (B) Chemical structures
of the siderophores enterobactin, salmochelin, yersiniabactin, and aerobactin. (DHBS)2 is the 2,3-dihydroxybenzoylserine dimer. Abs, absorbance.
ABU E. coli Siderophore Production
January 2012 Volume 80 Number 1 iai.asm.org 337
growth with the 83972 wild-type strain, competition assays were
performed. E. coli 83972 siderophore mutants were mixed at a 1:1
ratio with an ampicillin-resistant version of 83972 wild-type
(83972AMP) and cultured in MM9medium at pH 7.0 (containing
50 MDIP). The number of CFU of each strain was enumerated
after 7 h of growth. None of the 83972 siderophore mutants, in-
cluding 83972 Y and 83972 SY that had improved growth inmon-
ocultures, was able to outcompete strain 83972AMP, and in all cases
the relative fitness was not significantly different from 1 (Fig. 5).
Additionally, there was no significant difference in the final cell
densities of themixed cultures compared to those of themonocul-
tures. After 24 h, the proportion of each strain in themixed culture
was similar to that observed after 7 h of growth (data not shown).
Therefore, the 83972 siderophore biosyntheticmutants, including
the quadruple 83972 EASY mutant, were able to overcome the
growth deficiencies observed in single strain growth assays (Fig.
4A), suggesting that they act as cheaters by utilizing siderophores
produced by strain 83972AMP for growth.
E. coli 83972 siderophore receptormutants are outcompeted
by thewild-type strain during growth in iron-limitingmedium.
The ability of siderophore synthesis mutants to act as cheaters
necessitated the construction of siderophore receptor deletion
mutants in order to dissect the contribution of each siderophore
FIG 3 Liquid CAS assays for ABU E. coli strain 83972 wild-type and sidero-
phore biosynthetic deletion mutants in MM9 medium at pH 5.5 and pH 7.0.
Results are the means of biological triplicates plus standard deviations. Bar
graph shows percent siderophore units, calculated as [(Ar  As)/Ar]  100,
where Ar is the absorbance of MM9/CAS solution and As is the sample absor-
bance. The quadruple mutant E. coli 83972 EASY had negligible siderophore
activity at both pHs.
FIG 4 Growth of ABU E. coli strain 83972 wild type and siderophore biosynthetic deletion mutants inMM9mediumwith 50MDIP at pH 7.0 (A) and pH 5.5
(B). E. coli 83972 siderophore mutants with the same growth profile as the wild-type strain are not shown. Growth rates were calculated from the exponential
phase (2 to 5 h), and cell densities were determined from the 10-h time point. Results are themeans of biological triplicates standard deviations. Strains 83972
Y, 83972 SY, 83972 ES, 83972 EAS, and 83972 EASY had significantly different growth rates and cell densities after 10 h of growth than the wild-type E. coli 83972
at both pHs (P 0.05). Strain 83972 ESY had a significantly lower growth rate and final cell density than the wild-type E. coli 83972 at pH 7.0 (P 0.05).
FIG 5 Relative fitness of E. coli 83972 siderophore biosynthetic deletion mu-
tants compared to E. coli 83972AMP in amixed 1:1 growth experiment inMM9
mediumat pH7.0 containing 50MDIP. Fitness indexes were calculated after
7 h of growth by dividing the CFU/ml of each mutant by the CFU/ml of
83972AMP. The dashed line represents a fitness index of 1.0, which indicates no
difference in fitness between the two strains. The relative fitness of each E. coli
83972 biosynthetic mutant was not significantly different from 1.
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system to the fitness of E. coli 83972. The genes encoding the four
siderophore receptors FepA, IroN, IutA, and FyuAwere deleted to
give single, double, triple, and quadruple siderophore receptor
mutants. Unlike the biosynthetic mutants used previously, the
receptormutants synthesize and secrete the siderophores but can-
not take up and obtain iron from the siderophores. First, the re-
ceptor mutants were assessed for their ability to grow in MM9
medium at pH 7.0 containing 50 MDIP. The majority of the E.
coli 83972 receptor mutants (indicated by R superscripts) had no
change in growth rates compared to wild-type E. coli 83972 (i.e.,
83972 AR, 83972 YR, 83972 SR, 83972 ER, 83972 ASR, 83972 SYR,
83972AYR, 83972 EYR, 83972 EAR, 83972ASYR, and 83972 EAYR)
(data not shown). However, all mutants with deletions of both
enterobactin and salmochelin receptor genes (ESR) had signifi-
cantly decreased growth compared to wild-type E. coli 83972 (Fig.
6A). The growth rates of strains 83972 ESR and 83972 ESYR de-
creased by 90% and 92%, respectively, compared to growth of E.
coli 83972, with cell densities after 10 h of growth decreased by
79% and 82%, respectively (P  0.001). Strains 83972 EASR and
83972 EASYR, both ofwhich contained deletions in the enterobac-
tin, salmochelin, and aerobactin receptor genes, were unable to
grow in this iron-limiting medium.
Growth assays in MM9medium containing 50 MDIP at pH
5.5 yielded similar results (data not shown). Again, the only 83972
receptor mutants with statistically significant growth differences
compared to wild-type E. coli 83972 were 83972 ESR, 83972 EASR,
83972 ESYR, and 83972 EASYR. Compared to wild-type E. coli
83972, the cell densities after 10 h of growth of strains 83972 EASR
and 83972 EASYR (79 to 80% reduction) were more severely af-
fected than those of strains 83972 ESR and 83972 ESYR (49 to 51%
reduction) (P 0.05).
We also assessed the E. coli 83972 siderophore receptor mu-
tants in a mixed growth assay by directly competing each mutant
against E. coli 83972AMP in MM9medium containing 50 MDIP
at pH 7.0 for 7 h (Fig. 6B). Strains 83972 AR and 83972 YR showed
no difference in fitness compared to E. coli 83972AMP. In contrast,
the following mutants were significantly outcompeted by E. coli
83972AMP: 83972 SR, 83972 ER, 83972 ASR, 83972 SYR, 83972 AYR,
83972 EYR, 83972 EAR, 83972 ASYR, and 83972 EAYR (P 0.05).
The greatest fitness defects were seen for the four 83972 mutants
lacking the enterobactin and salmochelin receptor genes (ESR,
EASR, ESYR, and EASYR); in mixed growth assays with E. coli
83972AMP these strains constituted only 5 to 11% of the final pop-
ulation. This 10-fold decrease in fitness corresponds to the growth
deficiency observed for each of the four 83972 ESR mutants in
monoculture.
Enterobactin, salmochelin, aerobactin, and ferric citrate up-
take have a role in growth of E. coli 83972 in human urine. The
growth of E. coli 83972 wild-type and siderophore deletion mu-
tants was examined in single and mixed cultures using human
urine, which is themost physiologically relevant iron-limiting en-
vironment for this strain. In contrast toMM9medium containing
50MDIP, allE. coli 83972 siderophore biosyntheticmutants had
growth rates and cell densities after 10 h of growth similar to those
of wild-type E. coli 83972 when grown in urine (data not shown).
The addition of 50 M DIP to the urine had no effect on the
growth of any of the siderophore biosynthetic mutants compared
to wild-type E. coli 83972. To investigate whether citrate uptake
contributes to iron acquisition by E. coli 83972 during growth in
urine, the fecA gene encoding the ferric citrate receptor was de-
leted inE. coli 83972 (to produce the singlemutant 83972 F) and in
strain 83972 EASY (to produce the quadruple siderophore synthe-
sis/ferric citrate receptor strain 83972 EASYF). Strain 83972 F ex-
hibited the same growth characteristics as wild-type E. coli 83972
in urine with and without 50 M DIP (Fig. 7A). However, strain
83972 EASYF had a 63% decrease in growth rate (P 0.001) and
a 49% decrease in final cell density (P 0.001) compared to wild-
type E. coli 83972 in urine containing 50 M DIP. Mixed growth
assays (1:1) were also performed in human urine containing 50
M DIP to compare the growth of E. coli 83972 F, 83972 EASY,
and 83972 EASYF to that of E. coli 83972AMP. Strains E. coli 83972
F, 83972 EASY, and 83972 EASYF showed no significant differ-
ence in fitness compared to that of E. coli 83972AMP (data not
shown).
FIG 6 Growth and relative fitness of E. coli 83972 siderophore receptor dele-
tionmutants. (A)Growth inMM9medium, pH7.0, containing 50MDIP. E.
coli 83972 siderophore mutants with the same growth profile as the wild-type
strain are not shown. Strains 83972 ESR, 83972 EASR, 83972 ESYR, and 83972
EASYRhad significantly lower growth rates and lower cell densities after 10 h of
growth than wild-type E. coli 83972 (P 0.001). (B) Relative fitness of 83972
siderophore receptormutants compared to 83972AMP after amixed 1:1 growth
experiment inMM9medium at pH 7.0 containing 50MDIP. Results are the
means of biological triplicates  standard deviations. The dashed line repre-
sents a fitness index of 1.0, which indicates no difference in fitness between the
two strains. Strains 83972 ESR, 83972 EASR, 83972 ESYR, and 83972 EASYR
were severely outcompeted by E. coli 83972AMP (P 0.05). Strains 83972 SR,
83972 ER, 83972 ASR, 83972 SYR, 83972 AYR, 83972 EYR, 83972 EAR, 83972
ASYR, and 83972 EAYR were also significantly outcompeted by E. coli
83972AMP (P 0.05).
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In the case of the siderophore receptor mutants, strains 83972
ESR and 83972 ESYR displayed reduced growth rates (11% and
15%, respectively) and achieved lower cell densities after 10 h of
growth (14% and 17%, respectively) than the wild-type E. coli
83972 in human urine (P 0.05) (Fig. 7B). The growth of strains
83972 EASR and 83972 EASYR was evenmore compromised, with
their growth rates and cell densities after 10 h of growth signifi-
cantly affected compared to those of wild-type E. coli 83972 (P
0.05). The difference in growth rates and final cell densities of
strains 83972 ESR/83972 ESYR compared to 83972 EASR/83972
EASYR was also significant (P  0.05). While these trends were
similar to those in MM9 medium containing 50 M DIP, the
decrease in growth was not as pronounced, with growth of the
receptor mutants not completely abolished in urine. All other
83972 siderophore receptor mutants had no change in growth in
urine compared to wild-type E. coli 83972. Identical trends were
seen when 50 MDIP was added to the urine (data not shown).
Mixed assays (1:1) were also performed in urine to compare
the growth of each of the 83972 siderophore receptor mutants to
E. coli 83972AMP. Strains 83972 ESR, 83972 EASR, 83972 ESYR, and
83972 EASYR were significantly outcompeted by strain 83972AMP
(P 0.05) and constituted 29 to 45% of the final population (Fig.
7C). Similar results were seen when 50 MDIP was added to the
urine (data not shown). Thus, all 83972 mutants lacking both
enterobactin and salmochelin receptor genes had decreased fit-
ness in human urine.
Enterobactinandsalmochelin receptormutants areoutcom-
peted in the murine UTI model. To determine if E. coli 83972
siderophore receptor mutants with decreased fitness in iron-
limiting medium in vitro also have decreased fitness in vivo, E. coli
83972AMP was competed 1:1 with the 83972 ESR, EASR, ESYR, and
EASYR siderophore mutants in the mouse UTI model. E. coli
83972AMP significantly outcompeted mutants 83972 ESR, 83972
EASR, 83972 ESYR, and 83972 EASYR in urine, the bladder, and
the kidneys (P 0.05) (Fig. 8). These four strains have in common
mutations that disrupt the enterobactin receptor gene fepA (ER)
and the salmochelin receptor gene iroN (SR). There was no signif-
icant difference in the competitive index of the double mutant
83972 ESR and the quadruplemutant 83972 EASYR in urine, blad-
der, and kidneys. These results suggest that the enterobactin and
salmochelin receptors FepA and IroN together contribute to col-
onization of the urinary tract by E. coli 83972.
DISCUSSION
In this study we utilized the probiotic ABU E. coli strain 83972 to
analyze the relative importance of the enterobactin, salmochelin,
yersiniabactin, and aerobactin siderophore systems to iron acqui-
sition, growth, and fitness.We show that E. coli 83972 produces all
four siderophores during growth under low-iron conditions. To
overcome functional redundancy, we sequentially deleted the bio-
synthetic genes for each of the four systems to obtain all possible
combinations of 83972 siderophore biosynthetic mutants. We
also sequentially deleted the receptor genes for each of the four
siderophore systems to enable competition experiments. This
panel of isogenic mutants enabled a detailed investigation of the
contribution of each siderophore system to iron acquisition and
growth of the prototype ABU E. coli strain 83972.
Environmental factors such as pH and carbon source affect E.
coli siderophore activity (62). Thus, we initially analyzed the sid-
erophore activity of a collection of ABU E. coli isolates grown
under different conditions, i.e., glucose or glycerol as the carbon
source, as well as pH 5.5 and pH 7.0 to represent the pH range of
urine. Siderophore activity was significantly lower when strains
were grown with glucose at pH 5.5 than under the three other
conditions, and we therefore used glycerol defined medium
(MM9-glycerol) for detailed in vitro analysis of E. coli 83972 sid-
FIG 7 Growth and relative fitness of E. coli 83972 iron acquisition deletion
mutants in human urine. (A) Growth of 83972 wild-type, 83972 F, 83972
EASY, and 83972EASYF in humanurinewith 50MDIP. Strain 83972EASYF
had a significantly lower growth rate (P  0.001) and final cell density (P 
0.001) than wild-type E. coli 83972. (B) Growth of E. coli 83972 siderophore
receptormutants in human urine (noDIP). E. coli 83972 siderophore receptor
mutants with the same growth profile as the wild-type strain are not shown.
Strains 83972 ESR, 83972 EASR, 83972 ESYR, and 83972 EASYR displayed re-
duced growth rates and had lower cell densities after 10 h of growth than the
wild-type E. coli 83972 (P  0.05). (C) Relative fitness of 83972 siderophore
receptor mutants compared to 83972AMP after a mixed 1:1 growth experiment
in human urine (no DIP). Results are the means of biological triplicates 
standard deviations. The dashed line represents a fitness index of 1.0, which
indicates no difference in fitness between the two strains. Strains 83972 ESR,
83972 EASR, 83972 ESYR, and 83972 EASYRwere significantly outcompeted by
strain 83972AMP (P 0.05).
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erophore activity. Overall, the linked enterobactin and salmoche-
lin synthesis and uptake systems were consistently important for
siderophore activity, growth, andfitness ofE. coli 83972. The other
siderophore systems had different contributions depending on
the examined phenotype. It is important to remember that delet-
ing the enterobactin biosynthetic gene (entB) results in the loss of
both enterobactin and salmochelin siderophores, whereas delet-
ing a salmochelin biosynthetic gene (iroB) abolishes only salmo-
chelin production. With regard to E. coli 83972 total siderophore
activity, the loss of enterobactin/salmochelin or aerobactin sidero-
phores significantly decreased siderophore activity, whereas the
loss of salmochelin alone or yersiniabactin had no effect. The im-
portance of enterobactin and aerobactin over the other sidero-
phores at pH 7.0 is not simply related to their Fe3 binding affin-
ities. The binding affinity of yersiniabactin (dissociation constant
[Kd] of 1036M) is higher than that of aerobactin (Kd 1023M)
at neutral to alkaline pHs (47, 50). Enterobactin has the highest
Fe3 binding affinity (Kd 1052 M), and the binding affinity of
salmochelin is currently unknown (50). The importance of aero-
bactin but not enterobactin/salmochelin to siderophore activity at
pH 5.5 correlates with the higher production of aerobactin and
higher stability of Fe3-aerobactin in acidic environments (62).
The four different siderophores of E. coli 83972 displayed var-
ied contributions to growth in low-iron medium. For example,
FIG 8 Fitness of E. coli 83972 siderophore receptormutants during in vivo competition with E. coli 83972AMP. C3H/HeJmice were challenged with a 1:1mixture
of 83972AMP and 83972 ESR, 83972 EASR, 83972 ESYR, or 83972 EASYR. (A) Each dot represents total number of CFU recovered from eachmouse perml of urine
(i), per 0.1 g of bladder tissue (ii), or per 0.1 g of kidney tissue (iii). Lines connect data points for the same mouse, and horizontal bars represent median values.
WT, E. coli 83972AMP. (B) Each symbol represents the log10 fitness index calculated for each individual mouse. Fitness indices were calculated by dividing the
mutant CFU/ml of urine (i) or 0.1 g of bladder tissue (ii) or 0.1g of kidney tissue (iii) by that of 83972AMP. Dashed lines represent a log10 fitness index of 0, which
indicates no difference in fitness between the two strains.Horizontal bars represent groupmedians, and each competition grouphad 7 to 8mice. Allmutantswere
significantly outcompeted by 83972AMP in all three niches examined (P 0.05).
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growth of the enterobactin biosynthetic mutant 83972 ES was de-
creased while growth of the yersiniabactin biosynthetic mutant
83972 Y increased in comparison to that of E. coli 83972. Inacti-
vation of salmochelin or aerobactin synthesis alone had no effect
on growth. However, a role for aerobactin under these growth
conditions was demonstrated since strain 83972 EAS had signifi-
cantly decreased growth compared to strain 83972 ES. The impor-
tance of enterobactin for normal growth in vitro has been previ-
ously reported for E. coli K-12 as well as Klebsiella pneumonia and
Salmonella enterica serovar Typhimurium (39, 40, 66). Addition-
ally, increased growth of a Pseudomonas syringae yersiniabactin
mutant has been observed, possibly due to a highmetabolic cost of
yersiniabactin production (35). In our study, the growth benefit of
83972 Y was not enough to confer an advantage over strain
83972AMP in a mixed competition experiment.
Several of the siderophore receptor mutants demonstrated de-
creased growth in low-ironmedium compared to wild-type E. coli
83972. While the 83972 ER and 83972 SR mutants had no growth
defect compared to wild-type E. coli 83972, growth of the double
enterobactin/salmochelin receptor mutant 83972 ESR was se-
verely affected. The necessity to delete both catecholate receptors
can be explained by their redundancy; IroN is able to transport
both ferric enterobactin and ferric salmochelin, and FepA is able
to transport ferric enterobactin and, to a lesser extent, ferric sal-
mochelin (31, 49). E. coli 83972 also encodes other catecholate
receptors, including Iha (which can transport ferric enterobactin
and the enterobactin breakdown product DHBS), Cir (which can
transport ferricDHBS and ferric salmochelin), and Fiu (which can
transport ferric DHBS) (30, 31, 41). However, the poor growth of
E. coli 83972 ESR in low-iron medium suggests that these addi-
tional catecholate receptors did not compensate for the loss of
FepA and IroN under the conditions employed in these experi-
ments. There were also differences between the growth of the
83972 siderophore biosynthetic and receptor mutants; the recep-
tor mutant 83972 ESR had a significantly decreased growth rate
compared to that of the biosynthetic mutant 83972 ES in MM9
medium containing 50 M DIP at pH 7.0 (P 0.001). This may
be because the secretion of enterobactin and salmochelin by 83972
ESR results in the chelation of iron by molecules that cannot be
utilized. This observation has been previously reported for Yer-
sinia pestis yersiniabactin biosynthetic and receptor mutants (18).
The difference in growth of strains ESR/ESYR compared to EASR/
EASYR indicates a role for aerobactin (but not yersiniabactin)
during growth in low-iron medium.
We also examined the fitness of the mutants compared to that
of 83972AMP in mixed growth competition experiments. Compe-
tition experiments have been utilized to examine siderophore co-
operation and cheating characteristics in bacteria (26, 34). The
extensively studied pyoverdin siderophore of Pseudomonas
aeruginosa has a high metabolic cost of production, which results
in cheating in this bacterium (34). P. aeruginosa mutants that
cannot produce pyoverdin but can still utilize this siderophore
(i.e., cheaters) evolve spontaneously both in vitro and in the lungs
of patients with cystic fibrosis (15, 34). In this study, we show that
the 83972 biosynthetic mutants, including 83972 EASY, can act as
cheaters by utilizing the siderophores produced by 83972AMP to
rescue their growth deficiencies. However, since the mutants did
not outcompete 83972AMP, there was no fitness advantage gained
by avoiding the metabolic cost of production of any of the four
siderophores. Overall, this suggests that the additional iron acqui-
sition and flexibility afforded to E. coli 83972 by the production of
all four siderophores is worth the cost of producing its range of
siderophores.
A series of E. coli 83972 siderophore receptormutants was con-
structed and utilized to examine competition and fitness in a sce-
nario where the mutants were unable to cheat from the wild-type
E. coli 83972. Siderophore mutants with both enterobactin and
salmochelin receptor gene deletions (ESR) exhibited a 10-fold de-
crease in fitness compared to strain 83972AMP, which correlated
with the growth deficiency of these strains in monoculture. While
aerobactin and yersiniabactin single receptor mutants had no
change in fitness compared to strain 83972AMP, strain 83972 AYR
as well as 83972 ER and 83972 SR had a small but significant de-
crease in fitness which could not be detected in monoculture.
Since a previous study found that a yersiniabactin deletionmutant
in E. coli Nissle 1917 had decreased fitness in M63 medium, the
importance of siderophores may vary between strains and growth
conditions (62). The fact thatE. coli 83972 has all four siderophore
receptors could be advantageous in mixed species infections with
bacteria which do not have the full repertoire of receptors. Indeed,
E. coli 83972 outcompetes UPEC in human urine and in the
mouse UTI model, which is the basis for its use as a prophylactic
agent in patients with recurrent UTIs (54).
ABU E. coli 83972 was isolated from the urine of a young girl
who carried it for 3 years without UTI symptoms (42). E. coli
83972 grows very well in urine and outcompetes UPEC in human
urine and in a murine UTI model (54). Given that urine is the
most relevant medium for this strain, we repeated the growth and
competition assays in pooled human urine. The 83972 sidero-
phore biosynthetic mutants, including 83972 EASY, did not dis-
play a growth defect in urine, as seen inMM9medium containing
50 M DIP. It was necessary to further delete the ferric citrate
receptor fecA in 83972 EASY and also add 50 M DIP to see a
growth defect in urine. This suggests that pooled urine is not as
iron-limiting as MM9 medium and that the citrate content of
urine may be enough for iron acquisition in this assay. Of the
83972 receptor mutants, all mutants with both FepA and IroN
inactivated (ESR) had decreased growth in urine and decreased
fitness compared to wild-type E. coli 83972. These strains were
selected to be assessed in the mouse model of UTI.
The importance of the catecholate receptors FepA and IroN to
colonization of the mouse UTI model was evident with decreased
fitness of the 83972 ESR mutant in urine, the bladder, and the
kidneys. Since there was no difference between the competitive
indexes of 83972 ESR and 83972 EASYR, the IutA and FyuA recep-
torsmaynot contribute toE. coli 83972 colonization of this animal
model. Previous studies examining the role of iron acquisition
systems in vivo have largely focused on the colonization and viru-
lence of pathogenic bacteria. Several studies reported that entero-
bactin contributes to virulence of S. enterica serovar Typhi and S.
Typhimurium (22, 25, 66). However, conflicting studies utilizing
S.Typhimurium,K. pneumoniae, or avian-pathogenicE. colidem-
onstrated that enterobactin is not important for virulence (7, 10,
40, 61). Additionally, it has been shown that the salmochelin sys-
tem, which is linked to the enterobactin system, contributes to
virulence and is more likely to be functional in the host than en-
terobactin since it is not inactivated by host proteins (10, 13, 19,
45, 55). The enterobactin and salmochelin siderophore systems
are intrinsically linked at synthesis, secretion, and receptor levels,
making it difficult to completely distinguish the contributions to
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colonization and virulence by these two catecholate siderophores.
Recently, Garcia and coworkers found that aerobactin (IutA), ye-
rsiniabactin (FyuA), and heme receptors (ChuA and Hma) but
not catecholate receptors were important for virulence of the
UPEC strains CFT073 and 536 in a mouse UTImodel (23). While
a CFT073 fepA iha mutant was not attenuated in the mouse
model, a CFT073 fepA iroN (ESR) mutant was not examined.
Due to the redundancy of the catecholate receptors, it may be
necessary to delete most or all of the receptors (i.e., FepA, IroN,
Iha, Cir, and Fiu), depending on the strain. Indeed, one study
demonstrated that it was necessary to delete FepA, IroN, and Cir
receptors in S. Typhimurium before virulence attenuation was
achieved (48). Additionally, differences in the importance of the
enterobactin and salmochelin systems could be due to the asymp-
tomatic nature of E. coli 83972 compared to UPEC strains. It is
feasible that different siderophores are required by E. coli 83972,
which has less contact with host proteins since it does not adhere,
invade, or elicit an immune response (36). Finally, we note that
our UTI model employed the use of TLR4-deficient C3H/HeJ
mice since they develop higher levels of bacteriuria and thus en-
abled differences between E. coli 83972 wild-type and siderophore
deletion mutants to be more easily quantified. Thus, it is possible
that differences inmouse strain susceptibilitymay also account for
the differences observed between E. coli 83972 and CFT073.
Overall, for E. coli 83972 the linked catecholate enterobactin
and salmochelin systems were consistently important for iron ac-
quisition at pH 7.0, growth and fitness in low-iron medium,
growth and fitness in human urine, and fitness in the mouse UTI
model. This may be partially explained by the high Fe3 binding
affinity of enterobactin.However, we also identified contributions
of aerobactin to total siderophore activity at both pH 5.5 and 7.0
and a secondary role in growth where it partially compensated for
the loss of enterobactin. While yersiniabactin appears to be the
least important siderophore for E. coli 83972, it was produced,
functioned effectively as an iron chelator in the absence of the
other siderophores, and contributed to fitness of E. coli 83972 in
combination with other siderophores. Therefore, aerobactin and
yersiniabactin may provide a degree of functional redundancy in
certain environments or when the catecholate siderophores are
less efficient.
E. coli 83972maintained all four siderophore systems during its
3-year colonization of the bladder of a young girl, whereas genes
for type 1 fimbriae, P fimbriae, F1C fimbriae, and the hemolysin
toxin were inactivated (37, 53, 68). Several explanations for the
advantage of producing multiple siderophore systems have been
proposed: inactivation of some siderophores by host proteins,
e.g., enterobactin by serum albumin and siderocalin and aerobac-
tin by tear lipocalin (20, 24, 38); differential suitability for iron
acquisition in different environments, e.g., superiority of aerobac-
tin at acidic pHs (62); different preferred host iron sources (9);
differential ability of siderophore receptors to utilize exogenous
siderophores (e.g., FepA transports corynebactin while IroN
transports myxochelin C) (49); and also dual functions of sidero-
phore receptors (e.g., IroN mediates cell invasion and FyuA con-
tributes to biofilm formation [16, 28]). Despite this, there is still
the possibility of continued evolution in new hosts where the loss
of a specific siderophore system may be advantageous. For exam-
ple, Zdziarski and colleagues recently reported that an E. coli
83972 isolate during deliberate bladder colonization lost genes for
the aerobactin siderophore system, which is immunogenic, while
expression of the ferric citrate receptor FecAwas upregulated (67).
Thus, the major advantages of multiple iron uptake systems in
UTI-associated E. coli are likely to reflect the ability to successfully
compete for iron against both the host and other bacteria.
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